Recent abacavir use and incident cardiovascular disease in contemporary treated people living with HIV.
Open Access CRIS of the University of Bern · 01.03.2023
DOI: 10.48350/172357 ↗Kurz gefasst
Fachartikel in der Zeitschrift Open Access CRIS of the University of Bern, erschienen am 01.03.2023. Verfasst von Nadine Jaschinski und 42 weiteren Autor:innen.
Abstract (Originalsprache)
OBJECTIVE Assessing whether the previously reported association between abacavir (ABC) and cardiovascular disease (CVD) remained amongst contemporarily treated people living with HIV (PLWH). DESIGN Multinational cohort collaboration. METHODS RESPOND participants were followed from latest of 01/01/2012 or cohort enrolment until the first of a CVD event (myocardial infarction [MI], stroke, invasive cardiovascular procedure [ICP]), last follow-up or 31/12/2019. Logistic regression examined odds of starting ABC by 5-year CVD or chronic kidney disease (CKD) D:A:D risk score. We assessed associations between recent ABC use (use within past six months) and risk of CVD with negative binomial regression models, adjusted for potential confounders. RESULTS Of 29,340 individuals, 34% recently used ABC. Compared to those at low estimated CVD and CKD risks, the odds of starting ABC were significantly higher among individuals at high CKD risk (odds ratio 1.12 [95% confidence interval, 1.04-1.21]) and significantly lower for individuals at moderate, high or very high CVD risk (0.80 [0.72-0.88], 0.75 [0.64-0.87], 0.71 [0.56-0.90], respectively). During 6.2 years median follow-up (interquartile range; 3.87-7.52), there were 748 CVD events (incidence rate [IR] 4.7/1000 persons-years of follow up [4.3-5.0]). The adjusted CVD IR ratio was higher for individuals with recent ABC use (1.40 [1.20-1.64]) compared to individuals without, consistent across sensitivity analyses. The association did not differ according to estimated CVD (interaction p = 0.56) or CKD (p = 0.98) risk strata. CONCLUSION Within RESPOND's contemporarily treated population, a significant association between CVD incidence and recent ABC use was confirmed and not explained by preferential ABC use in individuals at increased CVD or CKD risk.
Schlagwörter
Zitieren
APA
Jaschinski, N., Greenberg, L., Neesgaard, B., Miró, M, J., Grabmeier‐Pfistershammer, K., Wandeler, Gilles, Smith, C. J., Wit, D., Stéphane, Wit, F. W., Pelchen–Matthews, A., Mussini, Cristina, Castagna, A., Pradier, C., Monforte, Antonella, …, & Lene (2023). Recent abacavir use and incident cardiovascular disease in contemporary treated people living with HIV. Open Access CRIS of the University of Bern. https://doi.org/10.48350/172357
Vancouver
Jaschinski N, Greenberg L, Neesgaard B, Miró, M J, Grabmeier‐Pfistershammer K, et al. Recent abacavir use and incident cardiovascular disease in contemporary treated people living with HIV. Open Access CRIS of the University of Bern. 2023. doi:10.48350/172357
BibTeX
@article{Jaschinski2023,
author = {Jaschinski, Nadine and Greenberg, Lauren and Neesgaard, Bastian and Miró and M, Jose and Grabmeier‐Pfistershammer, Katharina and Wandeler and Gilles and Smith, Colette J and Wit, De and Stéphane and Wit, Ferdinand W.N.M. and Pelchen–Matthews, Annegret and Mussini and Cristina and Castagna, Antonella and Pradier, Christian and Monforte and Antonella and Vehreschild and Jörg and Sönnerborg and Anders and Anne, Alain Volny and Carr, Andrew and Bansi‐Matharu, Loveleen and Lundgren, Jens Dilling and Garges, Harmony P. and Rogatto, Felipe and Zangerle and Robert and Günthard and F, Huldrych and Rasmussen, Line Dahlerup and Nescoi, Coca and Valk, Marc van der and Menozzi and Marianna and Muccini, Camilla and Mocroft, Amanda and Peters, Lars and Ryom and Lene},
title = {Recent abacavir use and incident cardiovascular disease in contemporary treated people living with HIV},
journal = {Open Access CRIS of the University of Bern},
year = {2023},
doi = {10.48350/172357}
}
EUVIMED